Spray drying to enable new inhaled drug products
Exploring the robustness of the pharmacopeial methods for testing dry powder inhalers (DPIs); Part 1: Delivered dose uniformity (DDU)
Back Page:
Research focus on nasal biopharmaceutics: A workshop by the Biopharmaceutics Focus Group of the APS
Cross-Industry Organizations:
An update from the Product Quality Research Institute (PQRI)
Application of biological models to inform research and development of inhalation products
Excipient enhanced growth (EEG): Expanding delivery options for the treatment of lung diseases
Back Pages:
Nestlé reconsidering only FDA-approved peanut allergy drug for children due to slow uptake
Food allergy bravery clinic helps children overcome anxiety
From the Archive:
Examining the influence of carrier lactose on the performance of dry powder inhaler (DPI) formulations: A case study
